Petco Health & Wellness Company, Inc.: Form 10-Q for the period ended Aug 1, 2026
Filed with the SEC on Sep 4, 2026 and accepted by EDGAR at Sep 4, 2026, 20:05 ET.
Management's discussion and analysis
As filed, 29,328 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the accompanying notes included elsewhere in this Quarterly Report on Form 10-Q (this “Form 10-Q”), as well as the corresponding Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in our Annual Report on Form 10-K for the fiscal year ended January 31, 2026 (the “2025 Form 10-K”). The discussion and analysis below contains certain forward-looking statements about our business and operations that are subject to the risks, uncertainties, and other factors referred to in Part II, Item 1A, “Risk Factors” of this Form 10-Q. These risks, uncertainties, and other factors could cause our actual results to differ materially from those expressed in, or implied by, the forward-looking statements. The risks described in this Form 10-Q and in other documents we file from time to time with the U.S. Securities and Exchange Commission (the “SEC”), including the section entitled “Forward-Looking Statements” in this Form 10-Q, should be carefully reviewed. All amounts herein are unaudited.
Overview
Petco Health and Wellness Company, Inc. (“Petco”, the “Company”, “we”, “our” and “us”) is a leading pet specialty retailer focused on improving the lives of pets, pet parents, and our own partners. We nurture the pet-human bond in the aisles of more than 1,500 Petco stores across the U.S., Mexico, and Chile.
Our multicategory strategy integrates our digital assets with our nationwide physical footprint to meet the needs of pet parents who are looking for a single source for all their pets' needs. Petco.com, our e-commerce site, and the Petco app, our personalized mobile app, together serve as hubs for pet parents to book appointments and manage all of their pets’ needs, while enabling them to shop wherever, whenever, and however they want. We are focused on continually improving both our digital capabilities as well as our membership offering.
We strive to be a company that is improving millions of pet lives as well as the lives of pet parents and the partners who work for us. In tandem with Petco Love, an independent 501(c)(3) nonprofit organization, we work with and support thousands of local animal welfare groups nationwide and, through these partnerships and in-store adoption events, we have helped find homes for over 7 million animals.
Macroeconomic factors, including interest rates, potential inflationary pressures, supply chain constraints, tariffs, and global economic and geopolitical developments, including geopolitical conflicts and tensions, have had varying impacts on our results of operations that are difficult to isolate and quantify. We cannot predict the duration or ultimate severity of these macroeconomic factors or the ultimate impact on our operations and liquidity. Please refer to the risk factors referred to in Part II, Item 1A, “Risk Factors” of this Form 10-Q.
How We Assess the Performance of Our Business
In assessing our performance, we consider a variety of performance and financial measures, including the following:
Comparable Sales
Comparable sales is an important measure throughout the retail industry and includes both retail and digital sales of products and services. A new location or digital site is included in comparable sales beginning on the first day of the fiscal month following 12 full fiscal months of operation and is subsequently compared to like time periods from the previous year. Relocated pet care centers become comparable pet care centers on the first day of operation if the original pet care center was open longer than 12 full fiscal months. If, during the period presented, a pet care center was closed, sales from that pet care center are included up to the first day of the month of closing. There may be variations in the way in which some of our competitors and other retailers calculate comparable sales. As a result, data in this filing regarding our comparable sales may not be comparable to similar data made available by other retailers.
Comparable sales allow us to evaluate how our overall ecosystem is performing by measuring the change in period-over-period net sales from locations and digital sites that have been open for the applicable period. We intend to improve comparable sales by continuing initiatives aimed to increase customer retention, frequency of visits, and basket size. General macroeconomic and retail business trends are also a key driver of changes in comparable sales.
Non-GAAP Financial Measures
Management and our board of directors review, in addition to GAAP (as defined herein) measures, certain non-GAAP financial measures, including Adjusted EBITDA and Free Cash Flow, to evaluate our operating performance, generate future operating plans, and make strategic decisions regarding the allocation of capital. Further explanations of these non-GAAP measures, along with reconciliations to their most comparable GAAP measures, are presented below under “Reconciliation of Non-GAAP Financial Measures to GAAP Measures.”
Executive Summary
Comparing the thirteen weeks ended August 1, 2026 with the thirteen weeks ended August 2, 2025 (unless otherwise noted), our results included the following:
- an increase in net sales to $1.49 billion, and a comparable sales increase of 0.6%;
- operating income of $47.8 million, inclusive of a $6.8 million net incremental tariff refund, compared to operating income of $43.0 million in the prior year period;
- net income attributable to Class A and B-1 common stockholders of $38.7 million, compared to $14.0 million in the prior year period; and
- an increase in Adjusted EBITDA from $113.9 million to $122.2 million, inclusive of a $6.8 million net incremental tariff refund.
Results of Operations
The following tables summarize our results of operations and the percent of net sales of line items included in our consolidated statements of operations (dollars in thousands):
| Net sales: | Thirteen weeks ended August 1, 2026 | August 2, 2025 | Twenty-six weeks ended August 1, 2026 | August 2, 2025 |
|---|---|---|---|---|
| Products | $1,216,857 | $1,225,605 | $2,444,944 | $2,467,496 |
| Services and other | 272,363 | 262,924 | 541,008 | 514,432 |
| Total net sales | 1,489,220 | 1,488,529 | 2,985,952 | 2,981,928 |
| Cost of sales: | ||||
| Products | 733,898 | 747,143 | 1,491,676 | 1,513,428 |
| Services and other | 164,175 | 156,067 | 328,704 | 313,213 |
| Total cost of sales | 898,073 | 903,210 | 1,820,380 | 1,826,641 |
| Gross profit | 591,147 | 585,319 | 1,165,572 | 1,155,287 |
| Selling, general and administrative expenses | 543,335 | 542,297 | 1,093,134 | 1,095,906 |
| Operating income | 47,812 | 43,022 | 72,438 | 59,381 |
| Interest income | (2,493) | (909) | (3,989) | (2,268) |
| Interest expense | 32,556 | 33,297 | 65,340 | 66,791 |
| Loss on extinguishment and modification of debt | — | — | 11,840 | — |
| Income (loss) before income taxes and income from equity method investees | 17,749 | 10,634 | (753) | (5,142) |
| Income tax (benefit) expense | (15,710) | 746 | (13,511) | 1,241 |
| Income from equity method investees | (5,201) | (4,084) | (10,756) | (8,694) |
| Net income attributable to Class A and B-1 common stockholders | $38,660 | $13,972 | $23,514 | $2,311 |
17
| Net sales: | Thirteen weeks ended August 1, 2026 | August 2, 2025 | Twenty-six weeks ended August 1, 2026 | August 2, 2025 |
|---|---|---|---|---|
| Products | 81.7% | 82.3% | 81.9% | 82.7% |
| Services and other | 18.3 | 17.7 | 18.1 | 17.3 |
| Total net sales | 100.0 | 100.0 | 100.0 | 100.0 |
| Cost of sales: | ||||
| Products | 49.3 | 50.2 | 50.0 | 50.8 |
| Services and other | 11.0 | 10.5 | 11.0 | 10.5 |
| Total cost of sales | 60.3 | 60.7 | 61.0 | 61.3 |
| Gross profit | 39.7 | 39.3 | 39.0 | 38.7 |
| Selling, general and administrative expenses | 36.5 | 36.4 | 36.6 | 36.8 |
| Operating income | 3.2 | 2.9 | 2.4 | 1.9 |
| Interest income | (0.2) | (0.1) | (0.1) | (0.1) |
| Interest expense | 2.2 | 2.3 | 2.1 | 2.2 |
| Loss on extinguishment and modification of debt | — | — | 0.4 | — |
| Income (loss) before income taxes and income from equity method investees | 1.2 | 0.7 | (0.0) | (0.2) |
| Income tax (benefit) expense | (1.1) | 0.1 | (0.5) | 0.0 |
| Income from equity method investees | (0.3) | (0.3) | (0.3) | (0.3) |
| Net income attributable to Class A and B-1 common stockholders | 2.6% | 0.9% | 0.8% | 0.1% |
| Operational Data: | Thirteen weeks ended August 1, 2026 | August 2, 2025 | Twenty-six weeks ended August 1, 2026 | August 2, 2025 |
|---|---|---|---|---|
| Comparable sales change | 0.6% | (1.4)% | 0.6% | (1.3)% |
| Total pet care centers (U.S.) at end of period | 1,377 | 1,388 | 1,377 | 1,388 |
| Adjusted EBITDA (in thousands) | $122,219 | $113,860 | $219,550 | $203,309 |
Thirteen and Twenty-six Weeks Ended August 1, 2026 Compared with Thirteen and Twenty-six Weeks Ended August 2, 2025
Net Sales and Comparable Sales
(dollars in thousands)
| Thirteen weeks ended August 1, 2026 | August 2, 2025 | $ Change | % Change | Twenty-six weeks ended August 1, 2026 | August 2, 2025 | $ Change | % Change | |
|---|---|---|---|---|---|---|---|---|
| Consumables | $731,279 | $729,918 | $1,361 | 0.2% | $1,478,106 | $1,477,988 | $118 | 0.0% |
| Supplies and companion animals | 485,578 | 495,687 | (10,109) | (2.0%) | 966,838 | 989,508 | (22,670) | (2.3%) |
| Services and other | 272,363 | 262,924 | 9,439 | 3.6% | 541,008 | 514,432 | 26,576 | 5.2% |
| Net sales | $1,489,220 | $1,488,529 | $691 | 0.0% | $2,985,952 | $2,981,928 | $4,024 | 0.1% |
Net sales increased $0.7 million to $1.49 billion in the thirteen weeks ended August 1, 2026 compared to net sales of $1.49 billion in the thirteen weeks ended August 2, 2025. Net sales increased $4.0 million to $2.99 billion in the twenty-six weeks ended August 1, 2026 compared to net sales of $2.98 billion in the twenty-six weeks ended August 2, 2025. Sales during the thirteen weeks ended August 1, 2026 reflect a temporary disruption from a stronger-than-expected response to our membership program relaunch. However, we continue to experience growth in our services business, driven by our investments in customer acquisition and retention, as well as optimization of our veterinary footprint. We also experienced positive comparable sales trends in our consumables category, offset by a lower pet care center count. We continue to focus on profitability and margin through a disciplined approach to managing unit costs, pricing, and promotional strategies.
We are unable to quantify certain factors impacting sales described above due to the fact that such factors are based on input measures or qualitative information that do not lend themselves to quantification.
Gross Profit
As a percentage of net sales, our gross profit rate was 39.7% for the thirteen weeks ended August 1, 2026 compared with 39.3% for the thirteen weeks ended August 2, 2025. As a percentage of net sales, our gross profit rate was 39.0% for the twenty-six weeks ended August 1, 2026 compared with 38.7% for the twenty-six weeks ended August 2, 2025. During the thirteen weeks ended August 1, 2026, the Company received substantially all refunds related to tariffs previously paid under the International Emergency Economic Powers Act ("IEEPA"). The period-over-period increase in gross profit rate was primarily driven by the net benefit of $6.8 million relating to gross refunds, net of an investment to propel the repositioning of new assortments for future growth, as well as incremental cost pressures related to fuel and tariff expense during the thirteen weeks ended August 1, 2026. We continue to focus on effectively utilizing our services footprint and managing our inventory, unit costs, pricing, and promotional strategies. We are unable to quantify the factors impacting gross profit rate described above due to the fact that such factors are based on input measures or qualitative information that do not lend themselves to quantification.
Selling, General and Administrative (“SG&A”) Expenses
As a percentage of net sales, SG&A expenses were 36.5% for the thirteen weeks ended August 1, 2026 compared with 36.4% for the thirteen weeks ended August 2, 2025. The increase in SG&A expenses between the periods was primarily due to an increase in advertising and depreciation expense, along with an increase in certain employee fringe benefits, as the thirteen weeks ended August 2, 2025 included improved actuarial results from employee benefits optimization initiatives. This was partially offset by lower payroll and other compensation costs.
As a percentage of net sales, SG&A expenses were 36.6% for the twenty-six weeks ended August 1, 2026 compared with 36.8% for the twenty-six weeks ended August 2, 2025. The decrease in SG&A expenses between the periods was primarily due to lower payroll, other compensation, and consulting costs, partially offset by an increase in advertising expenses, along with an increase in certain employee fringe benefits, as the twenty-six weeks ended August 2, 2025 included improved actuarial results from employee benefits optimization initiatives.
Interest Expense
Interest expense decreased $0.7 million, or 2.2%, to $32.6 million in the thirteen weeks ended August 1, 2026 compared with $33.3 million in the thirteen weeks ended August 2, 2025. Interest expense decreased $1.5 million, or 2.2%, to $65.3 million in the twenty-six weeks ended August 1, 2026 compared with $66.8 million in the twenty-six weeks ended August 2, 2025. The period-over-period decrease was primarily driven by a lower aggregate outstanding principal balance of indebtedness, partially offset by higher interest rates during the thirteen and twenty-six week periods ended August 1, 2026. For more information, refer to Note 3, “Senior Secured Credit Facilities,” and Note 4, "Senior Secured Notes" to the Notes to Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.
Loss on Extinguishment and Modification of Debt
Loss on extinguishment and modification of debt was $11.8 million for the twenty-six weeks ended August 1, 2026. This loss was recognized in conjunction with the February 2, 2026 debt refinancing transaction described under "Sources of Liquidity—Senior Secured Credit Facilities and Senior Secured Notes" below. There was no loss on debt extinguishment and modification of debt for the thirteen weeks ended August 1, 2026 or the thirteen and twenty-six weeks ended August 2, 2025. For more information, refer to Note 3, “Senior Secured Credit Facilities,” and Note 4, "Senior Secured Notes," to the Notes to Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.
Income Tax (Benefit) Expense
Our effective tax rates were (68.5)% and (135.1)%, resulting in income tax benefit of $15.7 million and $13.5 million for the thirteen and twenty-six weeks ended August 1, 2026, respectively, compared to effective tax rates of 5.1% and 34.9%, resulting in income tax expense of $0.7 million and $1.2 million for the thirteen and twenty-six weeks ended August 2, 2025, respectively. The change in effective tax rate was primarily driven by a $13.4 million reduction in unrecognized tax benefits, including accrued penalties and interest, following the successful completion of a federal tax refund review by the Joint Committee on Taxation in the quarter ended August 1, 2026. As of August 1, 2026, the Company’s liability for unrecognized tax benefits was $3.5 million.
Reconciliation of Non-GAAP Financial Measures to GAAP Measures
The following information provides definitions and reconciliations of certain non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with GAAP. Such non-GAAP financial measures are not calculated in accordance with GAAP and should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the most comparable GAAP measures. The non-GAAP financial measures presented may differ from similarly-titled measures used by other companies.
Adjusted EBITDA
We present Adjusted EBITDA, a non-GAAP financial measure, because we believe it enhances an investor’s understanding of our financial and operational performance by excluding certain material non-cash items, unusual or non-recurring items that we do not expect to continue in the future, and certain other adjustments we believe are or are not reflective of our ongoing operations and performance. Adjusted EBITDA enables operating performance to be reviewed across reporting periods on a consistent basis. We use Adjusted EBITDA as one of the principal measures to evaluate and monitor our operating financial performance and to compare our performance to others in our industry. We also use Adjusted EBITDA in connection with establishing discretionary annual incentive compensation targets, to make budgeting decisions, to make strategic decisions regarding the allocation of capital, and to report our quarterly results as defined in our debt agreements, although under such agreements the measure is calculated differently and is used for different purposes.
Adjusted EBITDA is not a substitute for net income (loss), the most comparable GAAP measure, and is subject to a number of limitations as a financial measure, so it should be used in conjunction with GAAP financial measures and not in isolation. There can be no assurances that we will not modify the presentation of Adjusted EBITDA in the future. In addition, other companies in our industry may define Adjusted EBITDA differently, limiting its usefulness as a comparative measure. Refer to Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Reconciliation of Non-GAAP Financial Measures to GAAP Measures” included in the 2025 Form 10-K for more information regarding how we define Adjusted EBITDA.
The table below reflects the calculation of Adjusted EBITDA and Adjusted EBITDA Margin for the periods presented:
(dollars in thousands)
| Thirteen weeks ended August 1, 2026 | August 2, 2025 | Twenty-six weeks ended August 1, 2026 | August 2, 2025 | |
|---|---|---|---|---|
| Net income attributable to Class A and B-1 common stockholders | $38,660 | $13,972 | $23,514 | $2,311 |
| Interest expense, net | 30,063 | 32,388 | 61,351 | 64,523 |
| Income tax (benefit) expense | (15,710) | 746 | (13,511) | 1,241 |
| Depreciation and amortization | 50,399 | 49,360 | 99,440 | 99,171 |
| Income from equity method investees | (5,201) | (4,084) | (10,756) | (8,694) |
| Loss on extinguishment and modification of debt | — | — | 11,840 | — |
| Equity-based compensation | 8,600 | 8,789 | 18,051 | 18,209 |
| Mexico joint venture EBITDA (1) | 13,139 | 10,360 | 26,055 | 20,558 |
| Other costs (2) | 2,269 | 2,329 | 3,566 | 5,990 |
| Adjusted EBITDA | $122,219 | $113,860 | $219,550 | $203,309 |
| Net sales | $1,489,220 | $1,488,529 | $2,985,952 | $2,981,928 |
| Net margin (3) | 2.6% | 0.9% | 0.8% | 0.1% |
| Adjusted EBITDA Margin | 8.2% | 7.6% | 7.4% | 6.8% |
(1) Mexico joint venture EBITDA represents 50% of the entity’s operating results for the periods presented, as adjusted to reflect the results on a basis comparable to our Adjusted EBITDA. In the financial statements, this joint venture is accounted for as an equity method investment and reported net of depreciation and income taxes. Because such a presentation would not reflect the adjustments made in our calculation of Adjusted EBITDA, we include our 50% interest in our Mexico joint venture on an Adjusted EBITDA basis to ensure consistency. The table below presents a reconciliation of Mexico joint venture net income to Mexico joint venture EBITDA:
(dollars in thousands)
| Thirteen weeks ended August 1, 2026 | August 2, 2025 | Twenty-six weeks ended August 1, 2026 | August 2, 2025 | |
|---|---|---|---|---|
| Net income | $10,402 | $8,167 | $21,506 | $17,387 |
| Depreciation | 8,838 | 6,793 | 17,144 | 13,390 |
| Income tax expense | 5,216 | 3,935 | 10,410 | 8,101 |
| Foreign currency loss | 326 | 696 | 470 | 404 |
| Interest expense, net | 1,496 | 1,129 | 2,579 | 1,833 |
| EBITDA | $26,278 | $20,720 | $52,109 | $41,115 |
| 50% of EBITDA | $13,139 | $10,360 | $26,055 | $20,558 |
(2) Other costs include, as incurred: restructuring costs and restructuring-related severance costs; legal reserves associated with significant, non-ordinary course legal or regulatory matters; and costs related to certain significant strategic transactions.
(3) We define net margin as net income attributable to Class A and B-1 common stockholders divided by net sales and Adjusted EBITDA margin as Adjusted EBITDA divided by net sales.
Free Cash Flow
Free Cash Flow is a non-GAAP financial measure that is calculated as net cash provided by operating activities less cash paid for fixed assets. Management believes that Free Cash Flow, which measures our ability to generate additional cash from our business operations, is an important financial measure for use in evaluating the Company’s financial performance.
The table below reflects the calculation of Free Cash Flow for the periods presented:
(dollars in thousands)
| Twenty-six weeks ended August 1, 2026 | August 2, 2025 | |
|---|---|---|
| Net cash provided by operating activities | $130,584 | $70,438 |
| Cash paid for fixed assets | (69,788) | (60,516) |
| Free Cash Flow | $60,796 | $9,922 |
Liquidity and Capital Resources
Overview
Our primary sources of liquidity are funds generated by operating activities and available capacity for borrowings on our $546.0 million ABL Revolving Credit Facility. Our ability to fund our operations, to make planned capital investments, to make scheduled debt payments and to repay or refinance indebtedness depends on our future operating performance and cash flows, which are subject to prevailing economic conditions and financial, business, and other factors, some of which are beyond our control. Our liquidity as of August 1, 2026 was $781.1 million, inclusive of cash and cash equivalents of $293.5 million and $487.6 million of availability on the ABL Revolving Credit Facility.
We are a party to contractual obligations involving commitments to make payments to third parties. These obligations impact our short-term and long-term liquidity and capital resource needs. We believe that our current resources, together with anticipated cash flows from operations and borrowing capacity under the ABL Revolving Credit Facility will be sufficient to finance our operations, meet our current cash requirements, and fund anticipated capital investments for at least the next 12 months. We may, however, seek additional financing to fund future growth or refinance our existing indebtedness through the debt capital markets, but we cannot be assured that such financing will be available on favorable terms, or at all.
Cash Flows
The following table summarizes our consolidated cash flows:
(dollars in thousands)
| Total cash provided by (used in): | Twenty-six weeks ended August 1, 2026 | August 2, 2025 |
|---|---|---|
| Operating activities | $130,584 | $70,438 |
| Investing activities | (69,292) | (58,091) |
| Financing activities | (36,202) | (4,280) |
| Net increase in cash, cash equivalents and restricted cash | $25,090 | $8,067 |
Operating Activities
Our primary source of operating cash is sales of products and services to customers, which are substantially all on a cash basis, and therefore provide us with a significant source of liquidity. Our primary uses of cash in operating activities include: purchases of inventory; freight and warehousing costs; employee-related expenditures; occupancy-related costs for our pet care centers, distribution centers and corporate support centers; credit card fees; interest under our debt agreements; and marketing expenses. Net cash provided by operating activities is impacted by our net income adjusted for certain non-cash items, including: depreciation and amortization; amortization of debt discounts and issuance costs; deferred income taxes; equity-based compensation; impairments of goodwill and intangible assets; other non-operating income; and the effect of changes in operating assets and liabilities.
Net cash provided by operating activities was $130.6 million in the twenty-six weeks ended August 1, 2026 compared with net cash provided by operating activities of $70.4 million in the twenty-six weeks ended August 2, 2025. The increase in operating cash flows were primarily driven by the timing of interest and rent payments, a decrease in inventory purchases, and the net impact of tariff refunds. This was partially offset by timing of invoice payments.
Investing Activities
Net cash used in investing activities was $69.3 million and $58.1 million for the twenty-six weeks ended August 1, 2026 and August 2, 2025, respectively, and consisted primarily of capital expenditures to support our business.
Financing Activities
Net cash used in financing activities was $36.2 million for the twenty-six weeks ended August 1, 2026, compared with $4.3 million used in financing activities for the twenty-six weeks ended August 2, 2025. Financing cash flows in the twenty-six weeks ended August 1, 2026 primarily consisted of payments of debt issuance costs and borrowings and repayments of debt in connection with the February 2, 2026 refinancing transaction discussed under "Sources of Liquidity" below. Financing cash flows in the twenty-six weeks ended August 2, 2025 were not material.
Sources of Liquidity
Senior Secured Credit Facilities and Senior Secured Notes
The Company had a secured term loan facility originally maturing on March 4, 2028 (the “First Lien Term Loan”), with an outstanding principal balance of $1,500.0 million as of January 31, 2026. On February 2, 2026, the Company entered into a refinancing amendment to the credit agreement governing the First Lien Term Loan (“Amended First Lien Term Loan”) and issued $600.0 million in aggregate principal amount of senior secured notes (the “Senior Secured Notes”). Following the amendment, $900.0 million of principal remained on the Amended First Lien Term Loan.
In September 2026, the Company voluntarily prepaid $75.0 million of the Amended First Lien Term Loan using existing cash on hand. The prepayment was applied to the remaining principal payments in order of scheduled payment date.
The Company has a secured asset-based revolving credit facility (as amended from time to time, the “ABL Revolving Credit Facility”). The first tranche of the ABL Revolving Credit Facility, which had availability of up to $35.0 million, subject to a borrowing base, matured on March 4, 2026. The remaining tranche has availability of up to $546.0 million, subject to a borrowing base, maturing on March 29, 2029.
For more information regarding this indebtedness, refer to Note 3, “Senior Secured Credit Facilities,” and Note 4 “Senior Secured Notes,” to the Notes to Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.
Derivative Instruments
The Company has entered into interest rate collar and swap agreements to limit the maximum interest on a portion of the Company’s variable-rate debt and decrease its exposure to interest rate variability relating to three-month Term SOFR. For more information regarding derivative instruments, refer to Note 5, “Derivative Instruments,” to the Notes to Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.
Critical Accounting Policies and Estimates
The preparation of our consolidated financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires us to make assumptions and estimates about future results and apply judgments that affect the reported amounts of assets, liabilities, net sales, expenses and related disclosures. We base our estimates and judgments on historical experience, current trends and other factors that we believe to be relevant at the time our consolidated financial statements are prepared. On an ongoing basis, we review the accounting policies, assumptions, estimates and judgments to ensure that our financial statements are presented fairly and in accordance with GAAP. However, because future events and their effects cannot be determined with certainty, actual results could differ from our assumptions and estimates, and such differences could be material.
There have been no material changes to our critical accounting policies and estimates as compared to the critical accounting policies and estimates described in the 2025 Form 10-K.
Recent Accounting Pronouncements
Refer to Note 1, “Summary of Significant Accounting Policies,” to the Notes to Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q for information regarding recently issued accounting pronouncements.
Market risk
As filed, 2,682 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
We are subject to market risks arising from transactions in the normal course of our business. These risks are primarily associated with interest rate fluctuations, as well as changes in our credit standing, based on the capital and credit markets, which are not predictable. We do not currently hold any instruments for trading purposes.
Interest Rate Risk
We are subject to interest rate risk in connection with the Amended First Lien Term Loan and the ABL Revolving Credit Facility. As of August 1, 2026, we had $897.8 million outstanding under the Amended First Lien Term Loan and no amounts outstanding under the ABL Revolving Credit Facility. The Amended First Lien Term Loan and the ABL Revolving Credit Facility each bear interest at variable rates. An increase of 100 basis points in the variable rates on the Amended First Lien Term Loan and the ABL Revolving Credit Facility as of August 1, 2026 would have increased annual cash interest in the aggregate by approximately $9.1 million. Additionally, we entered into cash flow hedges to limit the maximum interest rate on a portion of our variable-rate debt and limit our exposure to interest rate variability, refer to Note 5, “Derivative Instruments,” to the Notes to Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.
We cannot predict market fluctuations in interest rates and their impact on our debt, nor can there be any assurance that long-term fixed-rate debt will be available at favorable rates, if at all. Consequently, future results may differ materially from estimated results due to adverse changes in interest rates or debt availability.
Credit Risk
As of August 1, 2026, substantially all of our cash and cash equivalents were maintained at major financial institutions in the United States, and our current deposits are likely in excess of insured limits. We believe these institutions have sufficient assets and liquidity to conduct their operations in the ordinary course of business with little or no credit risk to us.
Foreign Currency Risk
Substantially all of our business is currently conducted in U.S. dollars, with a small amount denominated in foreign currencies. Our expenses are generally denominated in the currencies of the jurisdictions in which we conduct our operations. Our results of current and future operations and cash flows are subject to fluctuations due to changes in foreign currency exchange rates. We do not enter into forward currency contracts to hedge our foreign currency exposure. A hypothetical 10% change in foreign currency exchange rates applicable to our business would not have a material effect on our operating results.
Controls and procedures
As filed, 2,169 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Management’s Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required financial disclosure.
As of the end of the period covered by this Form 10-Q, our management, under the supervision and with the participation of our principal executive officer and principal financial officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Exchange Act Rules 13a-15(e) and 15d-15(e). Based upon this evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective at a reasonable assurance level as of August 1, 2026.
Changes in Internal Control over Financial Reporting
There was no change in our internal control over financial reporting that occurred during the quarter ended August 1, 2026, which has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Limitations on the Effectiveness of Controls
Our disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives. Management does not expect, however, that our disclosure controls and procedures will prevent or detect all error and fraud. Any control system, no matter how well designed and operated, is based on certain assumptions and can provide only reasonable, not absolute, assurance that its objectives will be met. Further, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within the Company have been detected.
Risk factors
As filed, 663 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Reference is made to Part I, Item 1A, “Risk Factors” included in the 2025 Form 10-K for information concerning risk factors. There have been no material changes with respect to the risk factors disclosed in the 2025 Form 10-K. You should carefully consider such factors, which could materially and adversely affect our business, financial condition and/or results of operations. The risks described in the 2025 Form 10-K are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially and adversely affect our business, financial condition and/or results of operations.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2026-08-01. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2026-05-03 to 2026-08-01 | $1.49bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2026-02-01 to 2026-08-01 | $2.99bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2026-05-03 to 2026-08-01 | $898.1m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2026-02-01 to 2026-08-01 | $1.82bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2026-05-03 to 2026-08-01 | $591.1m | us-gaap:GrossProfit |
| Gross profit | 6 months2026-02-01 to 2026-08-01 | $1.17bn | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2026-05-03 to 2026-08-01 | $543.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2026-02-01 to 2026-08-01 | $1.09bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2026-05-03 to 2026-08-01 | $47.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2026-02-01 to 2026-08-01 | $72.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2026-05-03 to 2026-08-01 | $32.6m | us-gaap:InterestExpenseNonoperating |
| Interest expense | 6 months2026-02-01 to 2026-08-01 | $65.3m | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months2026-05-03 to 2026-08-01 | −$15.7m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2026-02-01 to 2026-08-01 | −$13.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2026-05-03 to 2026-08-01 | $38.7m | us-gaap:NetIncomeLoss |
| Net income | 6 months2026-02-01 to 2026-08-01 | $23.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2026-05-03 to 2026-08-01 | $0.13 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2026-02-01 to 2026-08-01 | $0.08 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2026-05-03 to 2026-08-01 | $0.14 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2026-02-01 to 2026-08-01 | $0.08 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2026-05-03 to 2026-08-01 | 290,497,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2026-02-01 to 2026-08-01 | 289,691,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2026-02-01 to 2026-08-01 | $130.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2026-02-01 to 2026-08-01 | $69.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2026-08-01 | $293.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2026-08-01 | $1.05bn | us-gaap:AssetsCurrent |
| Total assets | At period end2026-08-01 | $5.17bn | us-gaap:Assets |
| Current liabilities | At period end2026-08-01 | $1.17bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2026-08-01 | $3.96bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2026-08-01 | $1.21bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001193125-26-383639. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.